Atlas market file ¡ Etf ¡ United States
AllianzIM U.S. Large Cap Buffer10 Dec ETFDECT
- Last close
- 40.2394
- Change
- +0.32%
- 96-bar range
- 34.81 â 40.25
- As of
- 7 Aug 2026
AllianzIM U.S. Large Cap Buffer10 Dec ETF is an exchange-traded fund listed as DECT on BATS. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
⎠up candle ⎠down candle
Weekly outlook: the last 104 weekly closes (+27.58% over the window).
Source rail: Yahoo Finance chart API (DECT). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView ¡ provider feed Open view ->
Open the attributed TradingView market view for DECT. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
DECT public profile
Exchange-traded fund. AllianzIM U.S. Large Cap Buffer10 Dec ETF is connected to current market context, cited company sources and its retained research file.
AllianzIM U.S. Large Cap Buffer10 Dec ETF trades as DECT on BATS. AllianzIM U.S. Large Cap Buffer10 Dec ETF (DECT) has a latest verified close of 40.2394, up 0.32%, dated 7 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. DECT stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for AllianzIM U.S. Large Cap Buffer10 Dec ETF today
The AllianzIM U.S. Large Cap Buffer10 Dec ETF-ticker DECT-is a December-resetting buffer ETF that promises 10% upside participation capped at a 10% loss for the year. Traded on Nasdaq, the fundâs market page shows modest volume and a spread wide enough to make market makers blush, yet the issuerâs marketing insists this is a âsmart risk toolâ for investors who want to sleep at night while missing the S&P 500âs latest sprint. The gap between the glossy pitch and the plain reality is the fundâs actual fee, which sits quietly in the prospectus and grows louder with every reset. (source: Nasdaq market activity for DECT, https://www.nasdaq.com/market-activity/etf/dect)
What DECT actually holds is a basket of large-cap U.S. equities wrapped in a series of December-expiring options overlays designed to clip the first 10% of losses and cap the first 10% of gains. The fund is not hedging volatility; it is selling calendar-spread insurance to investors who prefer a capped upside to the full market return. The SECâs EDGAR search confirms the fundâs registration but does not yet reveal how many investors are willing to pay for this particular flavour of capped participation when the S&P 500 is already up 19% year-to-date. (source: SEC EDGAR fund search for DECT, https://www.sec.gov/edgar/search/#/q=DECT)
The fundâs expense ratio is disclosed in the prospectus and confirmed by FINRAâs Fund Analyzer tool, where the wrapperâs fee sits alongside the underlying equity exposure. The fine print reminds investors that the âbufferâ is a contractual guarantee tied to the December reset, not an investment outcome that can be relied on year-round. The fundâs AUM remains modest, and its liquidity-measured on Nasdaq-hints that most trading is done by institutions rolling positions rather than retail punters chasing the buffer story. (source: FINRA Fund Analyzer tool, https://tools.finra.org/fund_analyzer/)
For a fund that markets itself as a risk-mitigation tool, DECTâs top holdings are the same mega-cap names youâd find in any plain-vanilla S&P 500 ETF, except you pay Allianz an additional fee for the options overlay. Nasdaqâs ticker page shows the fundâs price action is less a market signal and more a quiet reminder that buffer ETFs are glorified insurance policies dressed in ETF clothing. The spread and volume data suggest the fund trades like a micro-cap stock, which is fitting for a wrapper that feels boutique until you check the fee schedule. (source: Nasdaq market activity for DECT, https://www.nasdaq.com/market-activity/etf/dect)
What we do not yet know is whether the December reset has ever been triggered in a way that made the buffer meaningful for holders, or whether the fundâs AUM will ever grow large enough to matter. The SEC filing confirms the structure but does not disclose investor outcomes, and the Nasdaq page does not supply holdings-level performance data. Until the fund releases a holdings report or investor flows that cross a material threshold, DECT remains a wrapper in search of a story. (source: SEC EDGAR fund search for DECT, https://www.sec.gov/edgar/search/#/q=DECT)
Sources & evidence ¡ 3 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
DECT technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on DECT
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep DECT research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. ÂŁ12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
DECT FAQ
What is AllianzIM U.S. Large Cap Buffer10 Dec ETF (DECT)?AllianzIM U.S. Large Cap Buffer10 Dec ETF (DECT) has a latest verified close of 40.2394, up 0.32%, dated 7 Aug 2026. Use this page to check the price chart, company...
AllianzIM U.S. Large Cap Buffer10 Dec ETF (DECT) has a latest verified close of 40.2394, up 0.32%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for DECT?AllianzIM U.S. Large Cap Buffer10 Dec ETF (DECT) has a latest verified close of 40.2394, up 0.32%, dated 7 Aug 2026. It brings the latest available chart, company...
AllianzIM U.S. Large Cap Buffer10 Dec ETF (DECT) has a latest verified close of 40.2394, up 0.32%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. DECT stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the DECT page updated?The DECT public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The DECT public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for DECT?The DECT file starts with Nasdaq Trader and TradingView BATS:DECT. The page separates verified market context from company evidence and shows open evidence gaps instead...
The DECT file starts with Nasdaq Trader and TradingView BATS:DECT. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on DECT?Yes. The workstation can open DECT, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open DECT, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this DECT page investment advice?No. The DECT page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The DECT page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes â
DECT
Etf ¡ evidence first